Massachusetts Eye and Ear Infirmary
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Massachusetts Eye and Ear Infirmary sits in the top decile of US sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count).
Massachusetts Eye and Ear Infirmary: 73 sponsored US clinical trials, 20 recruiting.
Massachusetts Eye and Ear Infirmary sponsors 73 registered US clinical trials on ClinicalTrials.gov, 20 of them currently recruiting, and 36 completed. 8 of these trials are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Spasmodic Dysphonia, with 4 trials.
Top-decile sponsor footprint
Massachusetts Eye and Ear Infirmary ranks in the top decile of sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
36 of 44 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
73 total, page 1 of 2
Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait
NCT06688578
The Glaucoma and Retinopathy Screening Study
NCT06882356
ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty
NCT06753916
ctDNA in Cutaneous Squamous Cell Carcinoma
NCT06875609
A Trial of Hydrus Microstent Versus Goniotomy
NCT06289491
Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck
NCT06744296
Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
NCT06033703
Reminder-cue Scanning Training for Homonymous Visual Field Loss
NCT06136169
Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy
NCT06960616
Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor
NCT05150106
Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces
NCT05867173
Dropless Pars Plana Vitrectomy Study
NCT05331664
Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor
NCT05150093
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
NCT05317390
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
NCT05216770
Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
NCT04225611
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
NCT04735263
Feasibility Tests for Various Prism Configurations for Visual Field Loss
NCT04424979
Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy
NCT04440280
Brain Networks in Dystonia
NCT03042962
Simulated Walking With Multiplexing Prism for Field Expansion in Monocular Vision
NCT06024668
Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening
NCT06971276
Clinical Trial of Multi-Periscopic Prism Glasses for Hemianopia
NCT04827147
Doxycycline in Cutaneous Schwannoma (NF2)
NCT05521048
Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking
NCT05141604
Lenvatinib in Locally Advanced Invasive Thyroid Cancer
NCT04321954
Study of Aspirin in Patients With Vestibular Schwannoma
NCT03079999
Lactiplantibacillus Plantarum 299v Probiotic Supplementation in Patients With Diabetic Macular Edema
NCT07383701
Subconjunctival Humira for Boston Keratoprosthesis
NCT06926478
Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension
NCT04500574
Multiplexing Prism Fitting for Field Expansion of Monocular Vision
NCT06027216
Understanding Visual Confusion Using Stereoscopic Displays
NCT04957745
Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis
NCT04678115
Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty
NCT04752020
Anti-VEGF Therapy for Acute Thyroid Eye Disease
NCT04311606
ctDNA Liquid Biopsy for Early Assessment of Residual Disease in HPV-associated Head and Neck Cancer (Clear-HPVca)
NCT06730412
A Comparison of the Effect of Suture Material on Blepharoplasty Incision
NCT04585217
Clinical Trial to Improve the Magnetic Levator Prosthesis
NCT03818204
Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty
NCT04057053
Mobile Medical Application for Cost-effective Strabismus Screening
NCT03450980
Collision Warning Device for Blind and Visually Impaired
NCT03057496
Perioperative Complications of Deep Extubation in Adults
NCT04557683
Mucinex® for Treatment of Filamentary Keratitis
NCT02859246
5-fluorouracil Versus Placebo in Periocular Full Thickness Skin Grafts
NCT02705352
Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft
NCT02592330
Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
NCT02282917
Computer-Based Auditory Rehabilitation
NCT02147847
The Effect of Dexmedetomidine on Airway Complications After Deep or Awake Extubation
NCT02162433
Use of Amplification in Children With Unilateral Hearing Loss
NCT02269124
Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease
NCT01977781
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 13 |
| Phase 2 | 9 |
| Phase 3 | 1 |
| Phase 4 | 7 |
What is open in the Massachusetts Eye and Ear Infirmary pipeline
20 recruiting of 73 indexed (27% open); 36 completed (49%).
Phase mix: 8 late (III/IV) vs 22 early (I/II) (early-phase heavy).
Top condition: Spasmodic Dysphonia (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Massachusetts Eye and Ear Infirmary: open-pipeline peers nationwide
Peers matched on 73 registered trials and 27% open enrollment, not the therapeutic-area sidebar.
Massachusetts Eye and Ear Infirmary sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 73 trials (± recruiting share)
- Denver Health and Hospital Authority · 73 trials · 5% recruiting
- Hugo W. Moser Research Institute at Kennedy Krieger · 73 trials · 23% recruiting
- Joslin Diabetes Center · 73 trials · 10% recruiting
- Tulane University · 73 trials · 30% recruiting
Sponsors near 27% open enrollment (± trial volume)
- Connecticut Children's Medical Center · 27% recruiting · 55 trials
- Criterium · 27% recruiting · 11 trials
- Minneapolis Heart Institute Foundation · 27% recruiting · 22 trials
- Nerviano Medical Sciences · 27% recruiting · 11 trials
Related
What to do with this Massachusetts Eye and Ear Infirmary page
73 registered trials is a research-attention snapshot, not an endorsement of Massachusetts Eye and Ear Infirmary or any single study.
- 20 of Massachusetts Eye and Ear Infirmary's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Spasmodic Dysphonia is the condition Massachusetts Eye and Ear Infirmary studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Spasmodic Dysphonia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Massachusetts Eye and Ear Infirmary pipeline card: 73 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.